Press Release

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

Aug 16, 2022

Biden Administration and Congress Deliver Positive Progress on Longstanding Read More

CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE

Aug 12, 2022

Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Read More

CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

Aug 7, 2022

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down Read More

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

Jul 19, 2022

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Read More

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

Jul 12, 2022

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Read More

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES

Jun 29, 2022

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Read More

CSRXP AD CAMPAIGN: AMERICAN PEOPLE HAVE WAITED LONG ENOUGH; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE

Apr 28, 2022

Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game Read More

CSRXP: FINALIZED CMS COVERAGE DECISION FOR ADUHELM PROTECTS SENIORS AND TAXPAYERS FROM BIG PHARMA PRICE-GOUGING

Apr 8, 2022

Decision Appropriately Balances Access to Treatment with the Need for More Read More

CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION

Feb 15, 2022

FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Read More

CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD DRUG COMPANIES ACCOUNTABLE

Feb 7, 2022

Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Read More

CSRXP: BIG PHARMA’S BUSINESS-AS-USUAL APPROACH TO JANUARY PRICE HIKES UNDERSCORES URGENCY FOR RX SOLUTIONS

Feb 2, 2022

Drug Companies Increased Prices on 785 Brand Name Products in First Month of Read More

CSRXP STATEMENT AHEAD OF COMMITTEE VOTE FOR DR. ROBERT CALIFF TO LEAD U.S. FOOD AND DRUG ADMINISTRATION

Jan 12, 2022

Next FDA Commissioner Must Promote Competition, Transparency And Value In The Read More